• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高器官利用率以助力克服阿片类药物流行带来的悲剧。

Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic.

作者信息

Goldberg D S, Blumberg E, McCauley M, Abt P, Levine M

机构信息

Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.

Department of Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

出版信息

Am J Transplant. 2016 Oct;16(10):2836-2841. doi: 10.1111/ajt.13971. Epub 2016 Aug 24.

DOI:10.1111/ajt.13971
PMID:27438538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5462444/
Abstract

Death rates from drug overdoses have nearly doubled since 2003, with over 47 000 deaths in 2014. This is largely attributable to the opioid epidemic. If the unfortunate deaths of otherwise healthy people have yielded an increase in organ donors, then this might serve as perhaps the only comforting factor among this tragic and unnecessary loss of life. In this viewpoint, we present data from the Organ Procurement and Transplantation Network (OPTN) that show how the greatest relative increases in the mechanism of death among deceased donors from 2003 to 2014 were drug overdoses. Unfortunately, despite the absolute increase in the number of donors who died from a drug overdose, the mean organ yield was significantly lower than in other categories, in part due to concerns about disease transmission. In this paper, we present data on the changes in donation from donors with a drug overdose as a result of the opioid epidemic and discuss the need to educate transplant candidates and their physicians about the low risk of disease transmission compared to the greater risk of dying on a transplant waitlist.

摘要

自2003年以来,药物过量导致的死亡率几乎翻了一番,2014年有超过47000人死亡。这在很大程度上归因于阿片类药物流行。如果原本健康的人的不幸死亡导致器官捐献者增加,那么这可能是这场悲惨且不必要的生命损失中唯一令人欣慰的因素。在这一观点中,我们展示了器官获取与移植网络(OPTN)的数据,这些数据表明2003年至2014年期间,已故捐献者中死亡机制相对增加最多的是药物过量。不幸的是,尽管死于药物过量的捐献者数量绝对增加了,但平均器官获取量明显低于其他类别,部分原因是担心疾病传播。在本文中,我们展示了因阿片类药物流行导致药物过量的捐献者的捐献变化数据,并讨论了有必要让移植候选者及其医生了解疾病传播风险较低,而在移植等待名单上死亡的风险更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/e9d6b19d04d5/nihms861823f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/0a0b53b248bb/nihms861823f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/9e1b1a36bf7f/nihms861823f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/e9d6b19d04d5/nihms861823f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/0a0b53b248bb/nihms861823f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/9e1b1a36bf7f/nihms861823f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de6/5462444/e9d6b19d04d5/nihms861823f3.jpg

相似文献

1
Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic.提高器官利用率以助力克服阿片类药物流行带来的悲剧。
Am J Transplant. 2016 Oct;16(10):2836-2841. doi: 10.1111/ajt.13971. Epub 2016 Aug 24.
2
Impact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidates.OPTN 传染病政策和美国 PHS 增加风险供体指南对活体供体候选人的影响。
Am J Transplant. 2019 Dec;19(12):3233-3239. doi: 10.1111/ajt.15541. Epub 2019 Aug 14.
3
Use of public health service increased risk kidneys in pediatric renal transplant recipients.在小儿肾移植受者中,使用公共卫生服务会增加肾脏风险。
Pediatr Transplant. 2019 Aug;23(5):e13405. doi: 10.1111/petr.13405. Epub 2019 Jul 4.
4
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors.使用专门的供体护理机构进行供体管理与药物过量供体的器官利用率较高有关。
Clin Transplant. 2021 Mar;35(3):e14178. doi: 10.1111/ctr.14178. Epub 2020 Dec 14.
5
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.美国的药物过量流行和已故供体器官移植:国家登记研究。
Ann Intern Med. 2018 May 15;168(10):702-711. doi: 10.7326/M17-2451. Epub 2018 Apr 17.
6
United States donation after circulatory death liver transplantation is driven by a few high-utilization transplant centers.美国心脏死亡后器官捐献肝脏移植是由少数高利用率的移植中心推动的。
Am J Transplant. 2020 Jan;20(1):320-321. doi: 10.1111/ajt.15629. Epub 2019 Nov 1.
7
Importance of incorporating standardized, verifiable, objective metrics of organ procurement organization performance into discussions about organ allocation.将器官获取组织绩效的标准化、可核实、客观指标纳入器官分配讨论的重要性。
Am J Transplant. 2019 Nov;19(11):2973-2978. doi: 10.1111/ajt.15492. Epub 2019 Jul 1.
8
The Effect of the Opioid Epidemic on Donation After Circulatory Death Transplantation Outcomes.阿片类药物流行对循环死亡后捐献移植结局的影响。
Transplantation. 2019 May;103(5):973-979. doi: 10.1097/TP.0000000000002467.
9
Short-Term Graft Failure of Organs Procured from Drug-Related Deaths Compared with Other Causes of Death.与其他死亡原因相比,药物相关死亡获取的器官的短期移植物失败。
J Med Toxicol. 2021 Jan;17(1):37-41. doi: 10.1007/s13181-020-00801-8. Epub 2020 Aug 12.
10
OPTN/SRTR 2018 Annual Data Report: Deceased Organ Donation.OPTN/SRTR 2018 年度数据报告:已故器官捐赠。
Am J Transplant. 2020 Jan;20 Suppl s1:509-541. doi: 10.1111/ajt.15678.

引用本文的文献

1
Beyond boundaries: Redefining the donor frontier in pediatric lung transplantation.超越界限:重新定义小儿肺移植的供体范围
JHLT Open. 2025 Jul 25;10:100355. doi: 10.1016/j.jhlto.2025.100355. eCollection 2025 Nov.
2
A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart and lung transplantation.心脏和肺移植术后索磷布韦/维帕他韦与胺碘酮联合使用的单中心经验
JHLT Open. 2025 May 2;9:100279. doi: 10.1016/j.jhlto.2025.100279. eCollection 2025 Aug.
3
Utilization of Organs from Hepatitis C-Antibody-Positive or RNA-Positive Donors in Kidney Transplantation: A Single-Center Retrospective Analysis of Outcomes and Safety.

本文引用的文献

1
Changing the paradigm of organ utilization from PHS increased-risk donors: an opportunity whose time has come?改变器官利用模式,从公共卫生服务(PHS)高风险捐赠者入手:时机已至的机遇?
Clin Transplant. 2015 Sep;29(9):724-7. doi: 10.1111/ctr.12582. Epub 2015 Jul 23.
2
Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.尽管进行了核酸检测筛查,丙型肝炎病毒仍从器官捐献者传播。
Am J Transplant. 2015 Jul;15(7):1827-35. doi: 10.1111/ajt.13283. Epub 2015 May 5.
3
OPTN/SRTR 2013 Annual Data Report: kidney.OPTN/SRTR 2013 年度数据报告:肾脏。
丙型肝炎抗体阳性或RNA阳性供体器官在肾移植中的应用:一项关于结局和安全性的单中心回顾性分析
J Clin Med. 2025 Apr 12;14(8):2653. doi: 10.3390/jcm14082653.
4
Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia.丙肝病毒血症供体向无丙肝病毒血症受体进行实体器官移植的患者观点
Open Forum Infect Dis. 2024 Jan 10;11(3):ofae015. doi: 10.1093/ofid/ofae015. eCollection 2024 Mar.
5
Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.肾脏疾病患者丙型肝炎病毒和乙型肝炎病毒感染的管理。
Adv Kidney Dis Health. 2023 Jul;30(4):343-355. doi: 10.1053/j.akdh.2023.04.003.
6
The Association of the UNOS Heart Allocation Policy Change With Transplant and Left Ventricular Assist Device Access and Outcomes.《UNOS 心脏分配政策改变与移植和左心室辅助装置的可及性及结果的关联》。
Am J Cardiol. 2023 Oct 1;204:392-400. doi: 10.1016/j.amjcard.2023.07.090. Epub 2023 Aug 14.
7
Longer-Term Clinical Outcomes From the THINKER and EXPANDER Trials of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative Recipients.将丙型肝炎病毒核糖核酸阳性供体肾脏移植给丙型肝炎病毒阴性受者的THINKER和EXPANDER试验的长期临床结果
Kidney Int Rep. 2023 Apr 29;8(7):1460-1463. doi: 10.1016/j.ekir.2023.04.018. eCollection 2023 Jul.
8
Drug Overdose and Cardiovascular Deaths Among Deceased Organ Donors: Implications for Donor Utilization and Data Reporting.药物过量与器官捐献者的心血管死亡:对供体利用和数据报告的影响。
Ann Transplant. 2023 Jul 4;28:e940255. doi: 10.12659/AOT.940255.
9
Effectiveness of education and attitudes toward different types of deceased donor kidneys: Survey analysis of single-center experience.不同类型已故供体肾脏的教育和态度的效果:单中心经验的调查分析。
Front Public Health. 2023 Mar 29;11:1116823. doi: 10.3389/fpubh.2023.1116823. eCollection 2023.
10
Observational Study Examining Kidney Transplantation Outcomes Following Donation From Individuals That Died of Drug Toxicity in British Columbia, Canada.一项观察性研究:考察加拿大不列颠哥伦比亚省死于药物毒性个体捐赠后的肾移植结果。
Can J Kidney Health Dis. 2023 Apr 4;10:20543581231156853. doi: 10.1177/20543581231156853. eCollection 2023.
Am J Transplant. 2015 Jan;15 Suppl 2:1-34. doi: 10.1111/ajt.13195.
4
Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.2013年供体源性传播事件:器官获取与移植网络特设疾病传播咨询委员会报告
Transplantation. 2015 Feb;99(2):282-7. doi: 10.1097/TP.0000000000000584.
5
OPTN/SRTR 2012 Annual Data Report: lung.器官获取与移植网络/器官共享联合网络2012年度数据报告:肺脏
Am J Transplant. 2014 Jan;14 Suppl 1:139-65. doi: 10.1111/ajt.12584.
6
OPTN/SRTR 2012 Annual Data Report: heart.器官获取与移植网络/器官共享联合网络2012年度数据报告:心脏
Am J Transplant. 2014 Jan;14 Suppl 1:113-38. doi: 10.1111/ajt.12583.
7
OPTN/SRTR 2011 Annual Data Report: liver.OPTN/SRTR 2011 年度数据报告:肝脏。
Am J Transplant. 2013 Jan;13 Suppl 1:73-102. doi: 10.1111/ajt.12021.
8
Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States.美国 17 个器官获取组织中潜在器官捐献者感染人类免疫缺陷病毒和丙型肝炎病毒的风险估计。
Am J Transplant. 2011 Jun;11(6):1201-8. doi: 10.1111/j.1600-6143.2011.03518.x.